{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:51:17Z","timestamp":1792363877963,"version":"4.4.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["628946"],"award-info":[{"award-number":["628946"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["628946"],"award-info":[{"award-number":["628946"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-18-566256"],"award-info":[{"award-number":["AARF-18-566256"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-021151"],"award-info":[{"award-number":["MJFF-021151"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02914-2","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T19:04:49Z","timestamp":1753211089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Isomerized A\u03b2 in the brain can distinguish the status of amyloidosis in the Alzheimer\u2019s disease spectrum"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-4008","authenticated-orcid":false,"given":"Soumya","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5619-7306","authenticated-orcid":false,"given":"Celine","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-8294","authenticated-orcid":false,"given":"Keyla","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-5727","authenticated-orcid":false,"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-7940","authenticated-orcid":false,"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-0053","authenticated-orcid":false,"given":"Blaine R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"4","key":"2914_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/J.JAUT.2012.03.004","volume":"38","author":"NK Acharya","year":"2012","unstructured":"Acharya NK, Nagele EP, Han M et al (2012) Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. J Autoimmun 38(4):369\u2013380. https:\/\/doi.org\/10.1016\/J.JAUT.2012.03.004","journal-title":"J Autoimmun"},{"issue":"1","key":"2914_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2051-5960-1-83\/TABLES\/2","volume":"2","author":"YK Al-Hilaly","year":"2014","unstructured":"Al-Hilaly YK, Williams TL, Stewart-Parker M et al (2014) A central role for dityrosine crosslinking of Amyloid-\u03b2 in Alzheimer\u2019s disease. Acta Neuropathol Commun 2(1):1\u201317. https:\/\/doi.org\/10.1186\/2051-5960-1-83\/TABLES\/2","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"2914_CR3","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton NJ, Janelidze S, Mattsson-Carlgren N et al (2022) Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nature Med 28(12):2555\u20132562. https:\/\/doi.org\/10.1038\/s41591-022-02074-w","journal-title":"Nature Med"},{"issue":"6","key":"2914_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/J.NEURON.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y et al (2020) Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron 105(6):975-991.e7. https:\/\/doi.org\/10.1016\/J.NEURON.2019.12.015","journal-title":"Neuron"},{"issue":"4","key":"2914_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","volume":"3","author":"NR Barth\u00e9lemy","year":"2023","unstructured":"Barth\u00e9lemy NR, Saef B, Li Y et al (2023) CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease. Nat Aging 3(4):391\u2013401. https:\/\/doi.org\/10.1038\/s43587-023-00380-7","journal-title":"Nat Aging"},{"key":"2914_CR6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200861","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, Horie K, Sato C, Bateman RJ (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20200861","journal-title":"J Exp Med"},{"issue":"7","key":"2914_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nm1438","volume":"12","author":"RJ Bateman","year":"2006","unstructured":"Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-\u03b2 synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12(7):856\u2013861. https:\/\/doi.org\/10.1038\/nm1438","journal-title":"Nat Med"},{"issue":"40","key":"2914_CR8","doi-asserted-by":"publisher","first-page":"33304","DOI":"10.1074\/JBC.M112.395608","volume":"287","author":"J Bien","year":"2012","unstructured":"Bien J, Jefferson T, \u010cau\u0161evi\u0107 M et al (2012) The metalloprotease meprin \u03b2 generates amino terminal-truncated amyloid \u03b2 peptide species. J Biol Chem 287(40):33304. https:\/\/doi.org\/10.1074\/JBC.M112.395608","journal-title":"J Biol Chem"},{"issue":"4","key":"2914_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2914_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2914_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/BRAIN\/AWZ066","volume":"142","author":"G Brinkmalm","year":"2019","unstructured":"Brinkmalm G, Hong W, Wang Z et al (2019) Identification of neurotoxic cross-linked amyloid-\u03b2 dimers in the Alzheimer\u2019s brain. Brain 142(5):1441\u20131457. https:\/\/doi.org\/10.1093\/BRAIN\/AWZ066","journal-title":"Brain"},{"issue":"2","key":"2914_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/JPAD.2022.30\/TABLES\/3","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F et al (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimer Disease 9(2):197\u2013210. https:\/\/doi.org\/10.14283\/JPAD.2022.30\/TABLES\/3","journal-title":"J Prev Alzheimer Disease"},{"issue":"1","key":"2914_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/J.BBADIS.2017.07.005","volume":"1864","author":"E Cabrera","year":"2018","unstructured":"Cabrera E, Mathews P, Mezhericher E et al (2018) A\u03b2 truncated species: implications for brain clearance mechanisms and amyloid plaque deposition. Biochimica et Biophysica Acta (BBA) 1864(1):208\u2013225. https:\/\/doi.org\/10.1016\/J.BBADIS.2017.07.005","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2914_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/SCITRANSLMED.3002156\/SUPPL_FILE\/3-89RA57_SM","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR et al (2011) Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. https:\/\/doi.org\/10.1126\/SCITRANSLMED.3002156\/SUPPL_FILE\/3-89RA57_SM","journal-title":"Sci Transl Med"},{"issue":"16","key":"2914_CR15","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1021\/acschemneuro.3c00281","volume":"14","author":"T Chatterjee","year":"2023","unstructured":"Chatterjee T, Das G, Chatterjee BK, Ghosh S, Chakrabarti P (2023) The role of protein-L-isoaspartyl methyltransferase (PIMT) in the suppression of toxicity of the oligomeric form of A\u03b242, in addition to the inhibition of its fibrillization. ACS Chem Neurosci 14(16):2888\u20132901. https:\/\/doi.org\/10.1021\/acschemneuro.3c00281","journal-title":"ACS Chem Neurosci"},{"key":"2914_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005550","author":"JL Cummings","year":"2018","unstructured":"Cummings JL, Cohen S, van Dyck CH et al (2018) ABBY: a phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000005550","journal-title":"Neurology"},{"issue":"1","key":"2914_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"2914_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-018-21641-1","author":"G Di Fede","year":"2018","unstructured":"Di Fede G, Catania M, Maderna E et al (2018) Molecular subtypes of Alzheimer\u2019s disease. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-018-21641-1","journal-title":"Sci Rep"},{"issue":"1","key":"2914_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/NEUR.1996.0002","volume":"5","author":"H Fukumoto","year":"1996","unstructured":"Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T (1996) Association of A\u03b240-positive senile plaques with microglial cells in the brains of patients with Alzheimer\u2019s disease and in non-demented aged individuals. Neurodegeneration 5(1):13\u201317. https:\/\/doi.org\/10.1006\/NEUR.1996.0002","journal-title":"Neurodegeneration"},{"issue":"2","key":"2914_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0021-9258(19)75855-4","volume":"262","author":"T Geiger","year":"1987","unstructured":"Geiger T, Clarke S (1987) Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem 262(2):785\u2013794. https:\/\/doi.org\/10.1016\/S0021-9258(19)75855-4","journal-title":"J Biol Chem"},{"issue":"1","key":"2914_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-020-00719-X","volume":"12","author":"K Gnoth","year":"2020","unstructured":"Gnoth K, Piechotta A, Kleinschmidt M et al (2020) Targeting isoaspartate-modified A\u03b2 rescues behavioral deficits in transgenic mice with Alzheimer\u2019s disease-like pathology. Alzheimers Res Ther 12(1):1\u201320. https:\/\/doi.org\/10.1186\/S13195-020-00719-X","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2914_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","volume":"8","author":"M Goedert","year":"1992","unstructured":"Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8(1):159\u2013168. https:\/\/doi.org\/10.1016\/0896-6273(92)90117-V","journal-title":"Neuron"},{"issue":"13","key":"2914_CR23","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1074\/JBC.270.13.7013","volume":"270","author":"SA Gravina","year":"1995","unstructured":"Gravina SA, Ho L, Eckman CB et al (1995) Amyloid \u03b2 protein (A\u03b2) in Alzheimer\u2019s disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at A\u03b240 OR A\u03b242(43). J Biol Chem 270(13):7013\u20137016. https:\/\/doi.org\/10.1074\/JBC.270.13.7013","journal-title":"J Biol Chem"},{"issue":"1","key":"2914_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2019","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2019) Cerebral amyloid angiopathy and Alzheimer disease \u2014 one peptide, two pathways. Nature Rev Neurol 16(1):30\u201342. https:\/\/doi.org\/10.1038\/s41582-019-0281-2","journal-title":"Nature Rev Neurol"},{"key":"2914_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/ANNUREV.BI.58.070189.001443","volume":"58","author":"B Muller- Hill","year":"1989","unstructured":"Muller-Hill B, Beyreuther K (1989) Molecular biology of Alzheimer\u2019s disease. Annu Rev Biochem 58:287\u2013307. https:\/\/doi.org\/10.1146\/ANNUREV.BI.58.070189.001443","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"2914_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s40478-020-01019-z","volume":"8","author":"K Horie","year":"2020","unstructured":"Horie K, Barth\u00e9lemy NR, Mallipeddi N et al (2020) Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain. Acta Neuropathol Commun 8(1):149. https:\/\/doi.org\/10.1186\/s40478-020-01019-z","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"2914_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/brain\/awaa373","volume":"144","author":"K Horie","year":"2021","unstructured":"Horie K, Barth\u00e9lemy NR, Sato C, Bateman RJ (2021) CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer\u2019s disease. Brain 144(2):515\u2013527. https:\/\/doi.org\/10.1093\/brain\/awaa373","journal-title":"Brain"},{"issue":"1","key":"2914_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JALZ.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG et al (2012) National institute on aging\u2013Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8(1):1. https:\/\/doi.org\/10.1016\/J.JALZ.2011.10.007","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2914_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/JNR.20431","volume":"80","author":"A Ishigami","year":"2005","unstructured":"Ishigami A, Ohsawa T, Hiratsuka M et al (2005) Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer\u2019s disease. J Neurosci Res 80(1):120\u2013128. https:\/\/doi.org\/10.1002\/JNR.20431","journal-title":"J Neurosci Res"},{"issue":"5521","key":"2914_CR30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, Tsubuki S, Takaki Y et al (2001) Metabolic regulation of brain A\u03b2 by neprilysin. Science 292(5521):1550\u20131552. https:\/\/doi.org\/10.1126\/science.1059946","journal-title":"Science"},{"issue":"1","key":"2914_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13(1):45\u201353. https:\/\/doi.org\/10.1016\/0896-6273(94)90458-8","journal-title":"Neuron"},{"issue":"11","key":"2914_CR32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H et al (2021) Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease. JAMA Neurol 78(11):1375. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3180","journal-title":"JAMA Neurol"},{"issue":"1","key":"2914_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40478-017-0477-x","volume":"5","author":"N Kakuda","year":"2017","unstructured":"Kakuda N, Miyasaka T, Iwasaki N et al (2017) Distinct deposition of amyloid-\u03b2 species in brains with Alzheimer\u2019s disease pathology visualized with MALDI imaging mass spectrometry. Acta Neuropathol Commun 5(1):73. https:\/\/doi.org\/10.1186\/s40478-017-0477-x","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"2914_CR34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/S40265-024-02087-4","volume":"84","author":"C Kang","year":"2024","unstructured":"Kang C (2024) Donanemab: first approval. Drugs 84(10):1313\u20131318. https:\/\/doi.org\/10.1007\/S40265-024-02087-4","journal-title":"Drugs"},{"issue":"1","key":"2914_CR35","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1038\/s41467-025-59085-7","volume":"16","author":"S Koutarapu","year":"2025","unstructured":"Koutarapu S, Ge J, Dulewicz M et al (2025) Chemical imaging delineates A\u03b2 plaque polymorphism across the Alzheimer\u2019s disease spectrum. Nat Commun 16(1):3889. https:\/\/doi.org\/10.1038\/s41467-025-59085-7","journal-title":"Nat Commun"},{"issue":"3","key":"2914_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12640-013-9399-y","volume":"24","author":"SA Kozin","year":"2013","unstructured":"Kozin SA, Cheglakov IB, Ovsepyan AA et al (2013) Peripherally applied synthetic peptide isoAsp7-A\u03b2(1\u201342) triggers cerebral \u03b2-amyloidosis. Neurotox Res 24(3):370\u2013376. https:\/\/doi.org\/10.1007\/s12640-013-9399-y","journal-title":"Neurotox Res"},{"issue":"5","key":"2914_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/J.NEURON.2011.07.001","volume":"71","author":"MP Kummer","year":"2011","unstructured":"Kummer MP, Hermes M, Delekarte A et al (2011) Nitration of tyrosine 10 critically enhances amyloid \u03b2 aggregation and plaque formation. Neuron 71(5):833\u2013844. https:\/\/doi.org\/10.1016\/J.NEURON.2011.07.001","journal-title":"Neuron"},{"issue":"3","key":"2914_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ALZRT258\/FIGURES\/2","volume":"6","author":"MP Kummer","year":"2014","unstructured":"Kummer MP, Heneka MT (2014) Truncated and modified amyloid-beta species. Alzheimers Res Ther 6(3):1\u20139. https:\/\/doi.org\/10.1186\/ALZRT258\/FIGURES\/2","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2914_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/BBRC.1997.7083","volume":"237","author":"YM Kuo","year":"1997","unstructured":"Kuo YM, Emmerling MR, Woods AS, Cotter RJ, Roher AE (1997) Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem Biophys Res Commun 237(1):188\u2013191. https:\/\/doi.org\/10.1006\/BBRC.1997.7083","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2914_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/BBRC.1997.7083","volume":"237","author":"YM Kuo","year":"1997","unstructured":"Kuo YM, Emmerling MR, Woods AS, Cotter RJ, Roher AE (1997) Isolation, chemical characterization, and quantitation of A\u03b2 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem Biophys Res Commun 237(1):188\u2013191. https:\/\/doi.org\/10.1006\/BBRC.1997.7083","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2914_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1021\/ACSCENTSCI.9B00369\/ASSET\/IMAGES\/LARGE\/OC9B00369_0004.JPEG","volume":"5","author":"TR Lambeth","year":"2019","unstructured":"Lambeth TR, Riggs DL, Talbert LE et al (2019) Spontaneous isomerization of long-lived proteins provides a molecular mechanism for the lysosomal failure observed in Alzheimer\u2019s disease. ACS Cent Sci 5(8):1387\u20131395. https:\/\/doi.org\/10.1021\/ACSCENTSCI.9B00369\/ASSET\/IMAGES\/LARGE\/OC9B00369_0004.JPEG","journal-title":"ACS Cent Sci"},{"issue":"4","key":"2914_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ACN3.761","volume":"6","author":"C Leurent","year":"2019","unstructured":"Leurent C, Goodman JA, Zhang Y et al (2019) Immunotherapy with ponezumab for probable cerebral amyloid angiopathy. Ann Clin Transl Neurol 6(4):795. https:\/\/doi.org\/10.1002\/ACN3.761","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"2914_CR43","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1021\/ACS.ANALCHEM.5B03891\/ASSET\/IMAGES\/LARGE\/AC-2015-038914_0007.JPEG","volume":"88","author":"B Lyons","year":"2016","unstructured":"Lyons B, Friedrich M, Raftery M, Truscott R (2016) Amyloid plaque in the human brain can decompose from A\u03b2(1\u201340\/1-42) by spontaneous nonenzymatic processes. Anal Chem 88(5):2675\u20132684. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.5B03891\/ASSET\/IMAGES\/LARGE\/AC-2015-038914_0007.JPEG","journal-title":"Anal Chem"},{"issue":"1","key":"2914_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/S00401-014-1296-9","volume":"128","author":"M Mandler","year":"2014","unstructured":"Mandler M, Walker L, Santic R et al (2014) Pyroglutamylated amyloid-\u03b2 is associated with hyperphosphorylated tau and severity of Alzheimer\u2019s disease. Acta Neuropathol 128(1):67\u201379. https:\/\/doi.org\/10.1007\/S00401-014-1296-9","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2914_CR45","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci 82(12):4245\u20134249. https:\/\/doi.org\/10.1073\/pnas.82.12.4245","journal-title":"Proc Natl Acad Sci"},{"issue":"6012","key":"2914_CR46","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/SCIENCE.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330(6012):1774. https:\/\/doi.org\/10.1126\/SCIENCE.1197623","journal-title":"Science"},{"issue":"17","key":"2914_CR47","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1074\/JBC.RA118.006604","volume":"294","author":"W Michno","year":"2019","unstructured":"Michno W, Nystr\u00f6m S, Wehrli P et al (2019) Pyroglutamation of amyloid-\u03b2x-42 (A\u03b2x-42) followed by A\u03b21-40 deposition underlies plaque polymorphism in progressing Alzheimer\u2019s disease pathology. J Biol Chem 294(17):6719\u20136732. https:\/\/doi.org\/10.1074\/JBC.RA118.006604","journal-title":"J Biol Chem"},{"issue":"9","key":"2914_CR48","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41591-022-01925-w","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M, Ashton NJ, Shekari M et al (2022) Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat Med 28(9):1797\u20131801. https:\/\/doi.org\/10.1038\/s41591-022-01925-w","journal-title":"Nat Med"},{"issue":"1","key":"2914_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/ABBI.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J et al (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2032s disease. Arch Biochem Biophys 301(1):41\u201352. https:\/\/doi.org\/10.1006\/ABBI.1993.1112","journal-title":"Arch Biochem Biophys"},{"issue":"18","key":"2914_CR50","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C et al (2021) Donanemab in early Alzheimer\u2019s disease. N Engl J Med 384(18):1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"},{"issue":"4","key":"2914_CR51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41(4):479\u2013486. https:\/\/doi.org\/10.1212\/WNL.41.4.479","journal-title":"Neurology"},{"issue":"11","key":"2914_CR52","doi-asserted-by":"publisher","first-page":"e939","DOI":"10.1038\/cddis.2013.492","volume":"4","author":"VA Mitkevich","year":"2013","unstructured":"Mitkevich VA, Petrushanko IY, Yegorov YE et al (2013) Isomerization of Asp7 leads to increased toxic effect of amyloid-\u03b242 on human neuronal cells. Cell Death Dis 4(11):e939\u2013e939. https:\/\/doi.org\/10.1038\/cddis.2013.492","journal-title":"Cell Death Dis"},{"issue":"4","key":"2914_CR53","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/j.1471-4159.1992.tb08465.x","volume":"59","author":"RD Moir","year":"1992","unstructured":"Moir RD, Martins RN, Bush AI et al (1992) Human brain PA4 amyloid protein precursor of Alzheimer \u2019 s disease: purification and partial characterization. J Neurochem 59(4):1490\u20131498. https:\/\/doi.org\/10.1111\/j.1471-4159.1992.tb08465.x","journal-title":"J Neurochem"},{"issue":"1","key":"2914_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/BPA.13112","volume":"33","author":"M Montalbano","year":"2023","unstructured":"Montalbano M, Majmundar L, Sengupta U, Fung L, Kayed R (2023) Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with Lewy bodies. Brain Pathol 33(1):e13112. https:\/\/doi.org\/10.1111\/BPA.13112","journal-title":"Brain Pathol"},{"key":"2914_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab028","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S, Perez KA, Lago LC et al (2021) Quantification of N-terminal amyloid-\u03b2 isoforms reveals isomers are the most abundant form of the amyloid-\u03b2 peptide in sporadic Alzheimer\u2019s disease. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcab028","journal-title":"Brain Commun"},{"issue":"19","key":"2914_CR56","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1021\/acschemneuro.1c00474","volume":"12","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S, Perez KA, Dubois C et al (2021) Citrullination of amyloid-\u03b2 peptides in Alzheimer\u2019s disease. ACS Chem Neurosci 12(19):3719\u20133732. https:\/\/doi.org\/10.1021\/acschemneuro.1c00474","journal-title":"ACS Chem Neurosci"},{"key":"2914_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15713","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee S, Dubois C, Perez K et al (2022) Quantitative proteomics of tau and A\u03b2 in detergent fractions from Alzheimer\u2019s disease brains. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.15713","journal-title":"J Neurochem"},{"key":"2914_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-022-04055-x","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee S, Fjeldsted JC, Masters CL, Roberts BR (2022) Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software. Anal Bioanal Chem. https:\/\/doi.org\/10.1007\/s00216-022-04055-x","journal-title":"Anal Bioanal Chem"},{"issue":"11","key":"2914_CR59","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1021\/ACS.ANALCHEM.7B00941","volume":"89","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Kapp EA, Lothian A et al (2017) Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry. Anal Chem 89(11):6136\u20136145. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.7B00941","journal-title":"Anal Chem"},{"issue":"18","key":"2914_CR60","doi-asserted-by":"publisher","first-page":"8378","DOI":"10.1073\/PNAS.91.18.8378","volume":"91","author":"J N\u00e4slund","year":"1994","unstructured":"N\u00e4slund J, Schierhorn A, Hellman U et al (1994) Relative abundance of Alzheimer A\u03b2 amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A 91(18):8378\u20138382. https:\/\/doi.org\/10.1073\/PNAS.91.18.8378","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2914_CR61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.NEULET.2013.04.028","volume":"545","author":"AP Nicholas","year":"2013","unstructured":"Nicholas AP (2013) Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex. Neurosci Lett 545:107\u2013111. https:\/\/doi.org\/10.1016\/J.NEULET.2013.04.028","journal-title":"Neurosci Lett"},{"key":"2914_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"2914_CR63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/S41582-019-0222-0","volume":"15","author":"RW Paterson","year":"2019","unstructured":"Paterson RW, Gabelle A, Lucey BP et al (2019) Silk studies \u2014 capturing the turnover of proteins linked to neurodegenerative diseases. Nat Rev Neurol 15(7):419. https:\/\/doi.org\/10.1038\/S41582-019-0222-0","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2914_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/ana.24454","volume":"78","author":"BW Patterson","year":"2015","unstructured":"Patterson BW, Elbert DL, Mawuenyega KG et al (2015) Age and amyloid effects on human central nervous system amyloid-beta kinetics. Ann Neurol 78(3):439\u2013453. https:\/\/doi.org\/10.1002\/ana.24454","journal-title":"Ann Neurol"},{"issue":"2","key":"2914_CR65","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/S00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK et al (2010) Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol 120(2):185\u2013193. https:\/\/doi.org\/10.1007\/S00401-010-0690-1","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2914_CR66","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/BRAIN\/AWT362","volume":"137","author":"A Rijal Upadhaya","year":"2014","unstructured":"Rijal Upadhaya A, Kosterin I, Kumar S et al (2014) Biochemical stages of amyloid-\u03b2 peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease. Brain 137(3):887\u2013903. https:\/\/doi.org\/10.1093\/BRAIN\/AWT362","journal-title":"Brain"},{"issue":"5","key":"2914_CR67","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/BRAIN\/AWX057","volume":"140","author":"BR Roberts","year":"2017","unstructured":"Roberts BR, Lind M, Wagen AZ et al (2017) Biochemically-defined pools of amyloid-\u03b2 in sporadic Alzheimer\u2019s disease: correlation with amyloid PET. Brain 140(5):1486\u20131498. https:\/\/doi.org\/10.1093\/BRAIN\/AWX057","journal-title":"Brain"},{"issue":"6543","key":"2914_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA et al (1995) Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 376(6543):775\u2013778. https:\/\/doi.org\/10.1038\/376775a0","journal-title":"Nature"},{"issue":"8","key":"2914_CR69","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1073\/PNAS.83.8.2662","volume":"83","author":"A Roher","year":"1986","unstructured":"Roher A, Wolfe D, Palutke M, KuKuruga D (1986) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83(8):2662. https:\/\/doi.org\/10.1073\/PNAS.83.8.2662","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2914_CR70","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","volume":"268","author":"AE Roher","year":"1993","unstructured":"Roher AE, Lowenson JD, Clarke S et al (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer\u2019s disease. J Biol Chem 268(5):3072\u20133083","journal-title":"J Biol Chem"},{"key":"2914_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.NEUINT.2017.08.007","volume":"110","author":"AE Roher","year":"2017","unstructured":"Roher AE, Kokjohn TA, Clarke SG et al (2017) APP\/A\u03b2 structural diversity and Alzheimer\u2019s disease pathogenesis. Neurochem Int 110:1\u201313. https:\/\/doi.org\/10.1016\/J.NEUINT.2017.08.007","journal-title":"Neurochem Int"},{"issue":"8","key":"2914_CR72","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe CC, Ellis KA, Rimajova M et al (2010) Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging. Neurobiol Aging 31(8):1275\u20131283. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.007","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2914_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC, Iwatsubo T, Mann DMA, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct \u03b2-amyloid peptide species, A\u03b2N3(pE), in senile plaques. Neuron 14(2):457\u2013466. https:\/\/doi.org\/10.1016\/0896-6273(95)90301-1","journal-title":"Neuron"},{"issue":"17","key":"2914_CR74","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V et al (2019) High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93(17):e1647\u2013e1659. https:\/\/doi.org\/10.1212\/WNL.0000000000008081","journal-title":"Neurology"},{"issue":"1","key":"2914_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00401-024-02824-9","volume":"148","author":"S Schrempel","year":"2024","unstructured":"Schrempel S, Kottwitz AK, Piechotta A et al (2024) Identification of isoAsp7-A\u03b2 as a major A\u03b2 variant in Alzheimer\u2019s disease, dementia with Lewy bodies and vascular dementia. Acta Neuropathol 148(1):78. https:\/\/doi.org\/10.1007\/s00401-024-02824-9","journal-title":"Acta Neuropathol"},{"issue":"10","key":"2914_CR76","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1093\/BRAIN\/AWAB218","volume":"144","author":"J Schumacher","year":"2021","unstructured":"Schumacher J, Gunter JL, Przybelski SA et al (2021) Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks. Brain 144(10):3212\u20133225. https:\/\/doi.org\/10.1093\/BRAIN\/AWAB218","journal-title":"Brain"},{"issue":"6","key":"2914_CR77","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/J.1471-4159.1986.TB08501.X","volume":"46","author":"DJ Selkoe","year":"1986","unstructured":"Selkoe DJ, Abraham CR, Podlisny MB, Duffy LK (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer\u2019s disease. J Neurochem 46(6):1820\u20131834. https:\/\/doi.org\/10.1111\/J.1471-4159.1986.TB08501.X","journal-title":"J Neurochem"},{"issue":"2","key":"2914_CR78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/ABBI.2000.1955","volume":"381","author":"T Shimizu","year":"2000","unstructured":"Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T (2000) Isoaspartate formation and neurodegeneration in Alzheimer\u2019s disease. Arch Biochem Biophys 381(2):225\u2013234. https:\/\/doi.org\/10.1006\/ABBI.2000.1955","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"2914_CR79","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1016\/S0021-9258(18)83327-0","volume":"264","author":"RC Stephenson","year":"1989","unstructured":"Stephenson RC, Clarke S (1989) Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J Biol Chem 264(11):6164\u20136170. https:\/\/doi.org\/10.1016\/S0021-9258(18)83327-0","journal-title":"J Biol Chem"},{"issue":"2","key":"2914_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/S00401-014-1375-Y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC, F\u00e4ndrich M (2015) Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol 129(2):167\u2013182. https:\/\/doi.org\/10.1007\/S00401-014-1375-Y","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2914_CR81","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791\u20131800. https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"issue":"4","key":"2914_CR82","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/S41582-024-00942-2","volume":"20","author":"J Therriault","year":"2024","unstructured":"Therriault J, Schindler SE, Salvad\u00f3 G et al (2024) Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol 20(4):232\u2013244. https:\/\/doi.org\/10.1038\/S41582-024-00942-2","journal-title":"Nat Rev Neurol"},{"issue":"5440","key":"2914_CR83","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S et al (1999) \u0392-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735\u2013741. https:\/\/doi.org\/10.1126\/science.286.5440.735","journal-title":"Science"},{"issue":"7","key":"2914_CR84","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1021\/ACS.ANALCHEM.7B04936","volume":"90","author":"A V\u00e1zquez De La Torre","year":"2018","unstructured":"V\u00e1zquez De La Torre A, Gay M, Vilapriny\u00f3-Pascual S et al (2018) Direct evidence of the presence of cross-linked A\u03b2 dimers in the brains of Alzheimer\u2019s disease patients. Anal Chem 90(7):4552\u20134560. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.7B04936","journal-title":"Anal Chem"},{"issue":"2","key":"2914_CR85","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/S00401-018-1929-5","volume":"137","author":"S Walter","year":"2019","unstructured":"Walter S, Jumpertz T, H\u00fcttenrauch M et al (2019) The metalloprotease ADAMTS4 generates N-truncated A\u03b24-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer\u2019s disease. Acta Neuropathol 137(2):239\u2013257. https:\/\/doi.org\/10.1007\/S00401-018-1929-5","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2914_CR86","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling H, Mair W, Kumar M et al (2020) Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease. Cell 183(6):1699-1713.e13. https:\/\/doi.org\/10.1016\/j.cell.2020.10.029","journal-title":"Cell"},{"issue":"1","key":"2914_CR87","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1038\/s41598-017-10422-x","volume":"7","author":"NC Wildburger","year":"2017","unstructured":"Wildburger NC, Esparza TJ, LeDuc RD et al (2017) Diversity of amyloid-beta proteoforms in the Alzheimer\u2019s disease brain. Sci Rep 7(1):9520. https:\/\/doi.org\/10.1038\/s41598-017-10422-x","journal-title":"Sci Rep"},{"key":"2914_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/S13195-017-0309-Z","author":"O Wirths","year":"2017","unstructured":"Wirths O, Walter S, Kraus I et al (2017) N-truncated A\u03b24-x peptides in sporadic Alzheimer\u2019s disease cases and transgenic Alzheimer mouse models. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/S13195-017-0309-Z","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"2914_CR89","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1523\/JNEUROSCI.18-06-02063.1998","volume":"18","author":"A Yamamoto","year":"1998","unstructured":"Yamamoto A, Takagi H, Kitamura D et al (1998) Deficiency in protein l-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J Neurosci 18(6):2063\u20132074. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-06-02063.1998","journal-title":"J Neurosci"},{"issue":"6577","key":"2914_CR90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang Y, Arseni D, Zhang W et al (2022) Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains. Science 375(6577):167\u2013172. https:\/\/doi.org\/10.1126\/science.abm7285","journal-title":"Science"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02914-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02914-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02914-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:18:49Z","timestamp":1757269129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02914-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2914"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02914-2","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"7"}}